Chlorhexidine is a ubiquitous and highly effective antiseptic and disinfectant, crucial in healthcare settings for wound care, surgical scrubs, and oral hygiene products. The synthesis of this vital compound relies heavily on specific chemical intermediates. Among these, 1,3-Diaminoguanidine Monohydrochloride (CAS 36062-19-8) plays a pivotal role. For companies involved in pharmaceutical manufacturing, understanding the supply chain for this intermediate is key to ensuring consistent production of chlorhexidine-based products.

1,3-Diaminoguanidine Monohydrochloride: A Cornerstone Intermediate

Identified by CAS number 36062-19-8, 1,3-Diaminoguanidine Monohydrochloride is a chemical compound characterized by its white crystalline powder appearance. Its molecular structure makes it an ideal building block for creating more complex molecules. In the context of Chlorhexidine synthesis, it acts as a precursor, undergoing specific reaction pathways to form the final active ingredient. The demand for high-purity intermediates like this is continuous, driving the need for reliable global suppliers.

Sourcing and Procurement Insights

For pharmaceutical companies looking to buy 1,3-Diaminoguanidine Monohydrochloride, identifying a reputable manufacturer is essential. China-based chemical suppliers, such as NINGBO INNO PHARMCHEM CO.,LTD., are prominent players in this market, offering competitive pricing and reliable supply chains. When evaluating potential suppliers, key considerations include:

  • Purity: Ensuring the intermediate meets the high purity standards (e.g., 99.0%) required for pharmaceutical applications is non-negotiable.
  • Consistency: A stable supply of a consistent quality intermediate is vital to avoid production disruptions.
  • Technical Support: Access to technical data sheets and support can be invaluable for R&D teams.
  • Logistics: Efficient and timely delivery mechanisms are crucial for maintaining production schedules.

By prioritizing these aspects when looking to purchase 1,3-Diaminoguanidine Monohydrochloride, businesses can ensure the successful and cost-effective production of essential antiseptic products. Partnering with established chemical manufacturers in China offers a strategic advantage in securing this critical raw material.